SBIO Holdings Information

SBIO is an equity ETF with a total of 86 individual holdings. The top holdings are Kymera Therapeutics stock at 4.31%, Celcuity at 4.25%, Alkermes at 4.03%, Mirum Pharmaceuticals at 3.83%, and Spyre Therapeutics at 3.70%.

Total Holdings

Top 10 Percentage

34.98%

Asset Class

Equity

ETF Category

Health

Assets

156.14M

PE Ratio

n/a

Breakdown by Sector

Top 25 Holdings

No.	Symbol	Name	% Weight	Shares
1	KYMR	Kymera Therapeutics, Inc.	4.31%	83,447
2	CELC	Celcuity Inc.	4.25%	47,292
3	ALKS	Alkermes plc	4.03%	170,280
4	MIRM	Mirum Pharmaceuticals, Inc.	3.83%	61,676
5	SYRE	Spyre Therapeutics, Inc.	3.70%	80,278
6	CGON	CG Oncology, Inc.	3.58%	86,301
7	APGE	Apogee Therapeutics, Inc.	2.98%	57,237
8	XENE	Xenon Pharmaceuticals Inc.	2.98%	85,026
9	NAMS	NewAmsterdam Pharma Company N.V.	2.69%	117,518
10	TVTX	Travere Therapeutics, Inc.	2.63%	94,252
11	DNTH	Dianthus Therapeutics, Inc.	2.58%	45,454
12	CRNX	Crinetics Pharmaceuticals, Inc.	2.49%	106,985
13	ACAD	ACADIA Pharmaceuticals Inc.	2.34%	174,264
14	EWTX	Edgewise Therapeutics, Inc.	2.30%	109,647
15	VKTX	Viking Therapeutics, Inc.	2.23%	118,107
16	DNLI	Denali Therapeutics Inc.	1.95%	162,094
17	ORKA	Oruka Therapeutics, Inc.	1.92%	49,477
18	TARS	Tarsus Pharmaceuticals, Inc.	1.81%	43,501
19	GPCR	Structure Therapeutics Inc.	1.71%	72,407
20	IDYA	IDEAYA Biosciences, Inc.	1.70%	89,760
21	IRON	Disc Medicine, Inc.	1.67%	39,004
22	VERA	Vera Therapeutics, Inc.	1.62%	72,934
23	RLAY	Relay Therapeutics, Inc.	1.52%	182,676
24	MLYS	Mineralys Therapeutics, Inc.	1.47%	80,893
25	ZLAB	Zai Lab Limited	1.37%	114,065

Showing 25 of 86 holdings

Subscribe to see the full list

Activate Now

As of May 20, 2026